Part 2: Management of Toxicities for Novel Immunotherapy Agents
Young Bae, PharmD, BCPS, BCOP
Clinical Pharmacy Specialist, Hematology/Oncology/Stem Cell Therapy
Director, PGY2 Oncology Residency
Rush University Medical Center
Chicago, IL
Michael Schmidt, Pharm.D.
PGY2 Pharmacy Resident, Oncology
Rush University Medical Center
Chicago, IL
Part 2 is accredited for pharmacists and pharmacy technicians | 1.0 contact hour (0.1 CEU)
This is an independent program provided by ICHP.
Registration:
Register online below. Registration deadline is Friday, April 7 at 9:00 am.
This program is free to ICHP members. However, those who do not attend and do not cancel at least 48 hours prior to the program will be charged $50 to cover expenses. Pre-registration is required. Please bring a copy of your email registration confirmation with you to the meeting.
Seating is limited to the first 50 people. Student seating will limited to the first 10 students.
Learning Objectives for Pharmacists:
1. Describe the mechanism of action of CTLA-4, PD-1, and PDL-1 inhibitors.
2. Compare the key differences between immunotherapy and traditional chemotherapy toxicity profiles.
3. Identify the toxicity profiles of immunotherapy.
4. Select the appropriate treatment for immune-mediated adverse events.
Learning Objectives for Pharmacy Technicians:
1. Describe the difference between immunotherapy and traditional chemotherapy.
2. List the common immune-related adverse events seen with immunotherapy.
3. Recognize the time frame for presentation of immune-related adverse events.
ACPE # 0121-0000-17-039-L01-P & 0121-0000-17-039-L01-T
1.0 Contact Hour (0.1 CEU) Type of Activity: Knowledge-based
The Illinois Council of Health System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1.0 contact hour (0.1 CEU) of continuing pharmacy education credit.
Target Audience: Health-System Pharmacists and Pharmacy Technicians
PTCB requires CPhTs to submit 20 hours of pharmacy technician-specific (‘T-specific’) continuing pharmacy education (CPE) to qualify for recertification. Pharmacy technicians will no long be able to use Pharmacist only or P-specific CPE. In addition, PTCB reduced the number of allowable CPE hours earned through in-service training from 10 to 5. Please advise all pharmacy technicians at your site of this pending change. As an ACPE accredited provider, ICHP will continue to include Technician specific programming in most if not all of our CPE programming.
CPE Monitor: When registering for this program, you will be required to provide your NABP eProfile ID# and Birthday (MMDD) when registering for this meeting. This information is required by any participants seeking CPE credit.
Visit www.ichpnet.org/cpemonitor/ for information about CPE Monitor and how to obtain your NABP ID.
